Conflombardia – Europa
Territori d’Europa
Tutti gli articoli
www.ema.europa.eu [ad_1] Ivo Claassen joined EMA in 2018. Among many career highlights, Ivo and his team worked with the veterinary medicines network on the successful implementation of the 2019 Veterinary Medicinal Products Regulation. Ivo’s commitment to public and animal health, his outstanding...
www.ema.europa.eu [ad_1] Twelve new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended twelve medicines for approval at its July 2026 meeting. The committee recommended granting marketing authorisations for three medicines to treat adults with primary...
www.ema.europa.eu [ad_1] CVMP opinions on veterinary medicinal products The Committee adopted a positive opinion for a marketing authorisation for Bexatil for the reduction of hyperglycaemia in cats with diabetes mellitus not previously treated with insulin. The Committee adopted a positive...
www.ema.europa.eu [ad_1] EMA and the European Innovation Council and SMEs Executive Agency (EISMEA) have strengthened their cooperation in support of health innovation in the European Union (EU). Today, EMA’s Executive Director Emer Cooke and EISMEA’s Director Momchil Sabev signed a letter of...
www.ema.europa.eu [ad_1] EMA and the European Innovation Council and SMEs Executive Agency (EISMEA) have strengthened their cooperation in support of health innovation in the European Union (EU). Today, EMA’s Executive Director Emer Cooke and EISMEA’s Director Momchil Sabev signed a letter of...
www.ema.europa.eu [ad_1] Brussels, 14 July 2026 Dear Ms Jerkovic, dear honourable members, thank you for the invitation today and for this opportunity to report on EMA’s activities. Many of you know that it’s my last annual exchange with this committee, because my mandate will end in April, and I...